CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BusinessWire Biotech
Original article

GATX Corporation Reports 2026 Second-Quarter Results

EarningsPositive
AI Analysis

Summary

GATX Corporation reported Q2 2026 net income of $103.4 million ($2.84 per diluted share), up from $75.5 million ($2.06 per diluted share) in Q2 2025. This is not a biotech/pharmaceutical company announcement.

Financial Highlights

EPS

$2.84 per diluted share (Q2 2026); $2.06 per diluted share (Q2 2025)

Importance:2/10
Sentiment:
0.50
earningsquarterly_resultsfinancial_performance
Related Companies

Read the original article

Published by BusinessWire Biotech on July 30, 2026 12:30 PM

Read Original